Axonics Modulation Technologies, Inc. (AXNX)
Chart Events
Performance Outlook
| Previous Close | 52.75 |
| Open | 52.07 |
| Bid | 42.00 x 800 |
| Ask | 55.00 x 1000 |
| Day's Range | 51.07 - 52.50 |
| 52 Week Range | 15.25 - 53.86 |
| Volume | 386,593 |
| Avg. Volume | 495,412 |
| Market Cap | 2.058B |
| Beta (5Y Monthly) | 0.02 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.90 |
| Earnings Date | Nov 04, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 62.33 |
- Simply Wall St.
If You Had Bought Axonics Modulation Technologies (NASDAQ:AXNX) Shares A Year Ago You'd Have Earned 87% Returns
Passive investing in index funds can generate returns that roughly match the overall market. But you can significantly...
- Business Wire
Axonics® Announces Appointment of David M. Demski to Board of Directors
Axonics Modulation Technologies, Inc. (Nasdaq: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, today announced the appointment of veteran medical technology industry executive David M. Demski to its board of directors, effective January 1, 2021.
- Business Wire
Axonics® to Participate in Piper Sandler Virtual Healthcare Conference
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, is scheduled to participate in the Piper Sandler Virtual Healthcare Conference on December 1-2, 2020.
